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Abstract.  Addition of EGF to human carcinoma 
A-431  cells is known to induce membrane ruffling af- 
ter ~2 min (Chinkers,  M., J. A.  McKanna,  and S. 
Cohen.  1979.  J.  Cell Biol.  83:260-265) and the phos- 
phorylation of a protein referred to as p81,  a known 
substrate for various protein-tyrosine kinases (Cooper, 
J.  A.,  D.  F. Bowen-Pope, E.  Raines,  R. Ross, and 
T.  Hunter.  1982.  Cell. 31:263-273).  Ezrin,  a 
M/x,80,000 cytoskeletal protein of the isolated chicken 
microvillar core, is present in actin-containing  cell 
surface structures of a  wide variety of cells (Bretscher, 
A.  1983.  J.  Cell Biol.  97:425-432).  Ezrin  was then 
found to be homologous to p81  and to be phosphoryl- 
ated on tyrosine in response to EGF (Gould, K.  L., 
J. A.  Cooper, A.  Bretscher, and T.  Hunter.  1986. 
J.  Cell Biol.  102:660-669).  Here, the purification of 
ezrin from human placenta is described. Antibodies to 
human ezrin,  together with antibodies to other micro- 
filament-associated proteins,  were used to follow the 
distribution and phosphorylation of these proteins in 
A-431  cells after EGF treatment.  EGF induces the for- 
mation of microvillar-like  surface structures on these 
cells within 30 s and these give way to membrane 
ruffles at ~2-5  min after EGF addition;  the cells then 
round up after ~10-20 rain.  Ezrin  is recruited into the 
microvillar-like  structures and the membrane ruffles, 
and is phosphorylated on tyrosine and serine in a time 
course that parallels the formation and disappearance 
of these surface structures.  Spectrin is recruited into 
the membrane ruffles and shows a  similar rapid ki- 
netics of phosphorylation, but only on serine residues, 
and remains phosphorylated through the rounding up 
of the cells. The microvillar-like structures and mem- 
brane ruffles are also enriched in fimbrin and t~-ac- 
tinin.  Myosin becomes rapidly reorganized into a  stri- 
ated pattern that is consistent with it playing a  role in 
cell rounding.  These results show that two cortical 
proteins,  ezrin and spectrin,  become phosphorylated in 
a time course coincident with remodeling of the cell 
surface. The results are consistent with the notion that 
ezrin phosphorylation may play a  role in the formation 
of cell surface projections whereas spectrin phosphor- 
ylation may be involved in remodelling of more planar 
areas of the cell surface. 
C 
ELLS in multicellular organisms  respond to external 
signals in a variety of ways. Among the effectors that 
impinge on higher cells are growth factors  that  in- 
duce a number of changes  in their target cells (reviewed in 
Carpenter  and  Cohen,  1979;  Carpenter,  1987).  The  re- 
sponse of the human carcinoma A-431 cell line to added EGF 
has been extensively  studied as it contains  an abundance of 
surface receptors for this  growth factor (Fabricant et al., 
1977).  The only known enzymatic activity induced by the 
binding of EGF to its receptor is the induction,  on the cyto- 
plasmic  surface of the plasma membrane,  of its  intrinsic 
tyrosine kinase activity (Ushiro and Cohen,  1980). The re- 
sponse of the cells to EGF is complicated; very early re- 
sponses (in <30 s) include an increase in intracellular-free 
Ca  2+  and  the  generation  of  specific  inositol  phosphates 
(Moolenaar et al., 1986; Wheeler et al., 1987; Hepler et al., 
1987; Gonzalez et al.,  1988;  Wahl and Carpenter,  1988; 
Wahl et al., 1988). Some proteins,  including the receptor it- 
self, become phosphorylated on tyrosine over a period of 
minutes  to hours (Cohen et al.,  1980; Hunter and Cooper, 
1981;  Sawyer and  Cohen,  1985).  Over  the  first  several 
minutes the cells undergo a series of morphological changes 
that eventually result in their rounding up and the endocyto- 
sis  of the  bulk of the  receptors  (reviewed  in  Carpenter, 
1987).  Long term effects include  the stimulation  of DNA 
synthesis  and cell division. 
We are especially interested  in understanding  the molecu- 
lar details  of the rapid changes  in the microfilament  cyto- 
skeleton in A-431 cells in response to EGE Chinkers  et al. 
(1979,  1981) were the first to show that treatment  of A-431 
cells with EGF induced membrane ruffling after 2-5 min and 
ultimately induced the rounding up of these cells. Coincident 
with these early morphological changes  is a rapid increase 
in pinocytic activity (Haigler et al., 1979). With the discov- 
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the receptor, it became important to identify substrates for 
the receptor kinase as possible clues to its mode of action. 
Fava  and  Cohen  (1984)  identified  a  35-kD  polypeptide 
(known as p35) that was a substrate for the receptor kinase 
in vitro and Sawyer and Cohen (1985) found that p35 started 
to become phosphorylated in vivo ~30 min after EGF ad- 
dition.  Subsequently this polypeptide was  identified as  a 
lipocortin (Pepinsky and Sinclair, 1986).  Proteins identical 
and closely related to the A-431 cell p35 (Huang et al., 1986; 
Saris et al., 1986; see Brugge, 1986, for review) are localized 
under the plasma membrane in a pattern largely coincident 
with that of spectrin (Radke et al., 1983; Nigg et al., 1983; 
Greenberg  and  Edelman,  1983;  Mangeat  and  Burridge, 
1984).  Another substrate, known as p81, was identified in 
A-431 cells by Hunter and Cooper (1981) and found to be 
phosphorylated 2 min after addition of EGF, although its 
function and location was unknown. 
Over the last 10 yr we have been studying the molecular 
structure of the microvillar cytoskeleton  of chicken intestinal 
epithelial cells (Bretscher,  1986a).  Among the proteins of 
this structure that we have purified is a minor component 
with an apparent molecular mass of 80,000 D that we have 
termed ezrin (Bretscher,  1983, 1986b).  Using antibodies to 
ezrin we have shown that it is present, as expected, in the 
microvilli of fixed intestinal epithelial cells, and also in other 
cells in surface structures that contain an actin cytoskeleton 
(Bretscher,  1983).  The study of chicken intestinal ezrin has 
been hampered in part because the available protocols for its 
purification yield very small amounts of material (Bretscher, 
1983,  1986b);  consequently  nothing  is  currently  known 
about its function in this structure. The p81 protein-tyrosine 
kinase substrate identified  by Hunter and Cooper (1981) turns 
out to be identical or very closely related to chicken intestinal 
ezrin (Gould etal., 1986).  Thus there appears to be a close 
correlation between the  EGF-induced phosphorylation of 
p81  in A-431 cells noted by Hunter and Cooper (1981) and 
the rapid morphological changes induced by EGF in A-431 
cells as described by Chinkers etal. (1979, 1981). We wished 
to study this correlation in more detail, and investigate the 
possible participation of other key microfilament-associated 
proteins in these morphological changes. Although our anti- 
bodies to chicken ezrin cross react with the human protein 
in A-431 cells, they react much more weakly than with the 
chicken protein. It was therefore desirable to purify ezrin 
from a human source, preferably in quantities sufficient for 
biochemical studies,  and develop antibodies to it.  In this 
study  we  report  the  purification  of  ezrin  from  human 
placenta and the preparation of antibodies to it. We also de- 
scribe in more detail the defined series of morphological 
changes that occur in these cells in response to EGF, the lo- 
calization of actin, ezrin, spectrin and myosin, and the coin- 
cident phosphorylation of ezrin and spectrin during these 
changes. 
Materials and Methods 
Purification of Human Ezrin 
A key property of chicken and human ezrin is that they bind to hydruxyapa- 
tite under conditions where most other proteins do not; a hydroxyapatite 
column was an essential feature of ezrin purification from chicken brush 
borders (Bretscher, 1983,  1986b)  and is an essential feature of ezrin pnri- 
fication from human placenta. Human placenta obtained after Caesarian 
delivery was frozen as soon as possible and stored at  -70°C. Proteolysis 
is a problem during the purification of  ezrin from placenta, so all steps were 
performed at 4°C and all buffers were made 0.5 mM in PMSF and 0.5 mM 
in  benzamidine before  use.  80  g  of frozen  placenta  was  thawed  and 
homogenized in 320 ml 0.15 M NaC1,  1 mM EDTA, 1 mM DTT,  10 mM 
Tris-HCl, pH 7.5, in a blender (model 7011, Waring Products Div., New 
Hartford, CT) operating at full speed for 15 s. The homogenate was clarified 
at 47,000  g  for 20 min and the supernatant recovered and  100 #1 of di- 
isopropyl  fluorophosphate  (Aldrich  Chemical  Corp.,  Milwaukee,  WI) 
added to reduce proteolysis. The extract was made 40%  saturation (22.6 
g/ml) in ammonium sulfate and the precipitated material removed by cen- 
trifugation. The ammonium sulfate concentration was increased to 65 % (by 
addition of 15.3 g/100 ml) and the resulting precipitated material collected 
by centrifugation and dissolved in 20 ml of 20 mM NaCI,  1 mM DTT, 
10 mM Imidazole-HCl, pH 6.7, and dialyzed for 3 h against this buffer. Dur- 
ing this period a precipitate formed that was removed by centrifugation at 
47,000 g for 20 min. The clarified material was made 100 mM in phosphate 
from a 0.8-M KH2PO4-K2HPO4, pH 7.0, stock solution and applied to a 10- 
ml hydroxyapatite column (HA-Ultogel; LKB Instruments, Inc., Gaithers- 
burg, MD) equilibrated with 100 mM phosphate buffer.  The column was 
developed with a 40-ml gradient of 100-800 mM potassium phosphate, pH 
7.0, buffer.  Fractions were monitored by SDS-PAGE on 7 % minigels and 
fractions rich in ezrin pooled and dialyzed against 20 mM NaCI,  1 mM 
DTT,  20  mM Bis-tris-propane, pH 6.7, for 3 h.  The material was then 
filtered and applied to a Mono Q FPLC column (Pharmacia Fine Chemi- 
cals, Piscataway,  N J) and developed with a 40-ml gradient 20 mM to 1 M 
NaCI in the dialysis buffer.  Fractions rich in ezrin were pooled, dialyzed 
against 20 mM NaCI,  1 mM DTT,  20 mM MES, pH 6.7, and applied to 
a Mono S column (Pharmacia Fine Chemicals) and developed with a 40-ml 
gradient in this buffer from 20 to  1,000 mM NaCI.  Homogeneous ezrin 
eluted at ,'~440 mM NaCI. Essentially identical results were obtained when 
Q-Sepharose and S-Sepharose columns were substituted for the Mono Q 
and Mono S columns, respectively. 
Cell Culture, EGF Treatment, and rip_ and 
~S-labeling of Cells 
A-431  cells were obtained from the American Type Culture Collection 
(Rockville, MD) and grown in DME supplemented with 10% FCS (Gibco 
Laboratories, Grand Island, NY). Subconfluent cells were used in all ex- 
periments. For each experiment, cells in 100-ram plates were washed four 
times in filter-sterilized ABS buffer (6.4  g/liter NaC1; 0.3  g/liter CaCI2- 
2H:O; 0.4 g/liter KCI; 4 g/liter NaHCO3; 0.2 g/liter MgSO4-7H20; 1 g/li- 
ter glucose; 0.1 g/liter Na pyruvate; 2.13 g/liter BES, pH 7.4, with NaOH) 
at 37°C and then incubated for 1 h at 37°C in 4 ml ABS. When appropriate, 
0.5 mCi of 32p (Amersham Corp., Arlington Heights, IL; carrier-free) was 
added per 100-ram  plate and incubation continued for 1 h at 37°C.  EGF 
(Boehringer Mannheim Biochemicals, Indianapolis, IN;  receptor grade) 
was then added to a final concentration of 200 ng/ml and the cells incubated 
for appropriate times at 37°C. At the various time points, cells were quickly 
washed with 3 ml ABS at 4°C and scraped into 0.9-ml extraction buffer 
(0.6 M KCI, 0.1% SDS, 1% Triton X-100, 1% deoxycholate, 0.15 M NaCI, 
1 mM EDTA, 25 mM Tris, 100 #M NaVO4, 50 mM NaF, 0.25 mM PMSE 
0.5 mM benzamidine, pH 7.4). The samples were then clarified by centrifu- 
gation at 50,000 g at 4°C for I h before being subjected to immunoprecipita- 
tion.  For uniform 35S-labeling  of cells, cells were washed as described 
above, 200/~Ci [35S]methionine  (Translabel; Amersham Corp.) added per 
dish, incubated for 30 min at 37°C, and then the removed growth medium 
returned and the cells incubated overnight at 37°C.  The next day extracts 
were made as described above. 
Samples for phosphoamino acid analysis were immunoprecipitated, the 
respective bands excized from the gels, electrophoretically eluted, lyophi- 
lized, hydrolyzed, and subjected to one-dimensional analysis as described 
(Cooper etal.,  1983). 
Cytoskeletal preparations were made by adding 0.9 ml of room tempera- 
ture 0.5% Triton 3[-100, 75 mM KCI, 0.1 mM MgCI2,  1  mM EGTA,  10 
mM Imidazole-HCl, pH 7.4, to a 100-mm plate, recovering the soluble ma- 
terial, and then dissolving the cytoskeletal preparations as described for 
whole cells above.  Both the soluble material and dissolved cytoskeletal 
residues were used for immunoprecipitation. 
Immunoprecipitations 
100/~1 of extract was mixed with 20 ~tl of the appropriate antiserum and 
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icals;  LKB  Instruments Inc.) in RIPA-VF buffer  (0.1% SDS,  1%  Triton 
X-100, 1% deoxycholate, 0.14 M NaCI,  1 mM EDTA, 25 mM "Iris, 100 #M 
NaVO4, 50 mM NaF; 0.25 mM PMSF, 0.5 mM benzamidine, pH 7.4). The 
mixture was shaken for 2 h at 4°C and then the immunoprecipitate  washed 
10 times by briefly sedimenting the beads in a microfuge,  removing the su- 
pernatant, and resuspending the beads in 0.8 ml RIPA-VF buffer. The beads 
were then washed once in 25 mM Tris-HCi,  pH 7.5, resuspended  in 50 #1 
of double strength Laemmli sample buffer (Laemmli,  1970),  boiled, cen- 
trifuged, and the supernatants recovered for gel electrophoresis.  To elicit an- 
tibodies to human ezrin, pS1  from the Mono S column was subjected  to 
preparative SDS gel eleetrophoresis and used to immunize rabbits as de- 
scribed in detail (Bretscher,  1983). In outline, rabbits were injected with 0.5 
mg of ezrin in Freund's complete adjuvant,  then boosted with 0.5 mg ezrin 
in Freund's incomplete adjuvant on days 21 and 42.  10 d later the rabbits 
were found to have antibodies to ezrin as determined by double diffusion 
analysis and were  sacrificed  for their serum. The spectrin antiserum has 
been described (McOsker and Bretscher,  1985); the myosin antiserum was 
generated against the heavy chains of brush border myosin purified as de- 
scribed (Krizek et al., 1987), and excised from SDS gels. In immunoprecip- 
itation experiments on extracts of A431 cells using this antiserum, myosin 
heavy chain was precipitated,  but no coprecipitating  light chains could be 
detected.  Antiserum to chicken ezrin has been described (Bretscher,  1983). 
Immunofluorescence Microscopy 
Antigen affinity purified antibodies to brush border actin and spectrin were 
as described (Bretscher and Lynch, 1985; McOsker and Bretscher,  1985). 
Antibodies to human ezrin and myosin were purified from their antisera on 
purified  immobilized antigens as  described  (Bretscher,  1983).  For  im- 
munoffuorescence  microscopy,  cells were grown on coverslips and treated 
exactly  as described above for labeling the cells,  except that the 32p was 
omitted.  They were then plunged  into -20°C ethanol for 5 rain, and re- 
hydrated in PBS (Ca  2+-, MgE+-free). Antibodies in PBS was added to the 
coverslip and incubated at room temperature for 30 min. The primary anti- 
bodies were  used at the following  concentrations: anti-actin, 50 t~g/ml; 
anti-myosin, 50 #g/ml; anti-spectrin, 50 #g/ml; anti-human ezrin, 5 #g/ 
ml. The coverslips were washed with PBS, then with PBS made pH 9.0 by 
the addition of 10 mM Tris base, and again in PBS. The second antibody, 
fluorescein-labeled  goat anti-rabbit IgG (Miles Scientific Division, Naper- 
ville, IL) that had been preabsorbed on fixed A-431 cells,  was added at a 
dilution of 1:20. The coverslips were incubated at room temperature in the 
dark for 30 rain, washed in PBS, and mounted in medium containing phe- 
nyldiamine.  The cells were observed in a Zeiss Universal fluorescence  mi- 
croscope and cellular distributions recorded on Tri-X film (Eastman Kodak 
Co.,  Rochester,  NY). 
Results 
Purification of  Human Placental Ezrin and 
Characterization of  Ezrin Antibodies 
Ezrin has previously only been purified from chicken intesti- 
nal epithelial cells (Bretscher,  1983,  1986b). Polyclonal anti- 
bodies to this protein have identified a p81 polypeptide in hu- 
man  carcinoma  A-431  cells  that  is  immunologically  and 
chemically related to chicken ezrin  (Gould et al.,  1986). 
These antibodies have also revealed that it is present in human 
placental microvilli (Edwards and Booth, 1986). We therefore 
adapted our method for the isolation of  chicken ezrin to allow 
for its purification from human placenta; polypeptide com- 
positions at each step in the preparation are shown in Fig. 
1.  Both chicken and human ezrin bind strongly to hydrox- 
yapatite and this is the key step in the purification of the two 
proteins. After ammonium sulfate fractionation and dialysis 
of a placental extract, the material (Fig.  1, lane A) was ap- 
plied to a hydroxyapatite  column under conditions where the 
vast majority of proteins did not bind. After extensive wash- 
ing, the column was eluted with a phosphate gradient and two 
polypeptides, with apparent molecular masses of 81 and 77 
kD eluted towards the end of the gradient (lanes E-H). Frac- 
tions rich in the 81-kD polypeptide were pooled (lane I), dia- 
lyzed, and chromatographed on a Mono Q anion exchange 
column (lanes J-O). This yielded a highly enriched prepara- 
tion of the 81- and the 77-kD polypeptides and some minor 
species, most of which were proteolytic degradation prod- 
ucts.  Enriched fractions were  pooled  (lane P)  and chro- 
matographed on  a  Mono  S  cation  exchange resin  which 
yielded homogeneous 81-kD polypeptide (lane Q) and 77-kD 
polypeptide slightly contaminated with the 81-kD species 
(lane R). From 100 g of placenta we routinely obtain several 
Figure 1. 7.5 % SDS polyacrylamide gel of the steps in the purification of human placental ezrin. Lane A, proteins applied to hydroxyapatite 
column; Dane B-H, peak fractions eluting from the hydroxyapatite column; lane/, pooled fractions that were applied to the Mono Q column; 
lanes J-O, peak fractions from Mono Q column; lane P, pooled fractions that were applied to the Mono S column; lane Q, peak pS1 fraction 
from Mono S  column; lane R,  peak p79 fraction from Mono S  column.  Molecular mass standards are shown at left. 
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antibody to human  ezrin.  Coo- 
massie  Blue-stained  7.5% SDS 
gel is shown with (lane A) micro- 
villar  cores,  (lane  B)  placental 
extract loaded on hydroxyapatite 
column,  (lane  C)  purified  p81, 
(lane  D),  purified  p77. Lanes 
A'-D'  and  A"-D"  are  immuno- 
blots probed with antibody raised 
against  chicken  intestinal  ezrin 
(A'-D') and human placental (81 
kD) ezrin (lanes A"-D"). Lane S 
at left were the same molecular 
mass standards as shown in Fig. 
1.  Chicken ezrin is indicated as 
80K at left and the human p81 and 
p77 at right. 
milligrams of the Mono Q fractions, but poor recovery has 
been observed from the Mono S column yielding less than 
a  milligram of each polypeptide species.  Antibodies were 
elicited in rabbits to the Mono S purified 81 kD and char- 
acterized by  immunoblotting  (Fig.  2).  Antibodies  to  the 
chicken protein recognize both the 81- and 77-kD polypep- 
tides in crude placental extracts (lane B') and purified frac- 
tions  (lanes  C' and D').  Antibodies  to  the  81-kD  protein 
recognize chicken ezrin, although rather weakly (lane A"), 
and the placental 81-kD polypeptide (lanes B" and C") but 
not, surprisingly, the 77-kD polypeptide (lanes B" and D", the 
slight contamination of  the 77-kD polypeptide with the 81-kD 
species is responsible for the reactivity seen in lane D"). 
These results indicate that the placental 81-kD is human ez- 
rin; the 77-kD polypeptide might be a degradation product, 
or more likely, a protein closely related to the 81-kD human 
ezrin. 
Ezrin and Spectrin Become Specifically 
Phosphorylated after EGF Treatment of  A-431 Cells 
Since we knew that ezrin is a substrate for a tyrosine kinase 
activity after treatment of  these cells with EGF (Gould et al., 
1986), we wanted to explore the state of phosphorylation as 
a function of time after the addition of EGF. In addition, we 
chose to examine the phosphorylation state of two other pro- 
teins, spectrin and myosin, believed to play key roles in cellu- 
lar shape changes. 
The antisera to human ezrin,  myosin heavy chain,  and 
spectrin were first characterized with respect to their ability 
to immunoprecipitate the relevant proteins from 35S-labeled 
A-431 cells (Fig. 3). A single polypeptide of 81 kD was im- 
munoprecipitated by the antiserum to human ezrin (lane A), 
a single polypeptide of 200 kD by the antiserum to myosin 
heavy chain (lane C), and a doublet at ,~240K by the spectrin 
antiserum (lanes B  and D).  Although this antiserum only 
reacts  with  the  240K  subunit  of spectrin  (McOsker  and 
Bretscher, 1985), immunoprecipitation conditions were cho- 
sen to maintain the 235K/240K spectrin heterodimer; hence 
both chains were recovered in the immunoprecipitates. 
To explore the effect of EGF treatment on protein phos- 
phorylation, A-431  cells were prelabeled with 32p for 1 h 
and proteins then analyzed for 32p content at various times 
after EGF addition.  A time course after EGF addition re- 
Figure 3. Immunoprecipitation of ezrin, spectrin, and myosin from 
A-431 cells. 35S-labeled cells were harvested, extracts made, and 
were subjected to immunoprecipitation. The resulting immuno- 
precipitates were resolved on a 6.5 % SDS gel and subjected to auto- 
radiography. Lane A, material precipitated with antiserum to hu- 
man ezrin; lanes B and D, material precipitated with antiserum to 
spectrin; lane C, material precipitated with antiserum to myosin 
heavy chains. Lane D is part of the gel with a lower loading of the 
immunoprecipitate to show that both the ct and/$ chains of non- 
erythroid spectrin, as indicated, are immunoprecipitated. 
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for 1 h and then EGF was added. At each time point the cells were harvested, and the relevant proteins immunoprecipitated from extracts. 
The figure shows the relative amount of 32p in ezrin (o) and spectrin (o) as a function of time as determined by scanning densitometry 
of the autoradiograms shown. The zero time point was just before addition of EGF to the culture. Resolution of the spectrin immunoprecipi- 
tates on lower percentage gels revealed that all the radioactivity was found in the ~ chain. 
vealed no obvious changes in phosphorylation pattern when 
total phosphoproteins were analyzed by gel electrophoresis 
(not  shown).  However, by immunoprecipitation we  found 
that  both  spectrin and  ezrin became phosphorylated in  a 
time-dependent manner (Fig. 4). Before addition, no radio- 
activity was associated with the immunoprecipitated ezrin or 
myosin heavy chains,  and  a  small  amount  with  spectrin. 
Samples taken at various times after EGF addition revealed 
that ezrin became significantly phosphorylated after 30 s, 
peaking at ~2-5  min,  and then the phosphorylation level 
declined until the end of the experiment at 20 min. Spectrin 
phosphorylation also rapidly increased upon EGF addition, 
rising rapidly over the first 2 min, and then reaching a pla- 
teau at 5-20 min.  Resolution on lower percentage gels re- 
vealed that  all  the  label  was  incorporated into  the  235K 
~-subunit of nonerythroid spectrin (not shown).  No phos- 
phorylation of the myosin heavy chains  was  detected.  In 
parallel experiments with 35S-labeled cells, the amounts of 
ezrin, spectrin, and myosin did not change during EGF treat- 
ment (not shown). 
Earlier  work  has  revealed  that  human  ezrin  is  phos- 
phorylated on tyrosine and threonine in response to EGF in 
A-431 cells (Gould et al.,  1986). We therefore analyzed the 
phosphoamino acids present in ezrin 2 min after EGF addi- 
tion and in spectrin 5  min after EGF addition (Fig.  5). In 
hydrolysates of ezrin, labeled phospho-serine and phospho- 
tyrosine were found, but only phospho-serine in hydrolysates 
of spectrin. 
Localization of  Actin, Ezrin, Spectrin, and Myosin in 
A-431 Cells after Treatment with EGF 
A-431 cells are known to undergo a series of rapid morpho- 
logical changes in response to the addition of EGF (Chinkers 
Figure 5. Phosphoamino acid analysis of ezrin 2 min after EGF ad- 
dition,  and  spectrin  5  min  after  EGF addition.  Ezrin  contains 
phospho-serine  and  phospho-tyrosine,  whereas  only  phospho- 
serine is evident in the spectrin sample. 
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tribution of some key microfilament-associated proteins by in- 
direct immunofluorescence microscopy during these changes. 
The distribution of actin, myosin, ezrin, and spectrin was ex- 
amined by immunofluorescence microscopy in A-431 cells 
before or after treatment with EGE These cells are very poor 
subjects for the localization of proteins by immunofluores- 
cence microscopy as they are rather rounded,  the typical 
morphology of transformed cells. However, some aspects of 
the localization of  these proteins could be clearly determined 
from these experiments. An overview of these events is shown 
in Fig. 6. Higher resolution micrographs of early events are 
shown in Fig. 7. 
The localization of actin revealed a complicated series of 
surface events immediately after EGF treatment (Fig. 6, top 
row). Unstimulated cells revealed a rather featureless image. 
30 s after EGF addition (the earliest reliable time point), an 
abundance of surface structures resembling large microvilli 
were found covering the entire surface of the cells.  These 
structures then gave way to membrane ruffles that initiated 
at the edge of cells and were very prominent at 2-5 min after 
EGF addition; these are presumably the membrane ruffles 
described  by  Chinkers  et  al.  (1979).  The  surface  activ- 
ity then declined and the cells rounded up; this was essential- 
ly complete at 20 min (top row, last column). Immunofluo- 
rescence microscopy was then used to explore the distribution 
of the selected proteins during the remodeling of  the cell sur- 
face.  Ezrin was  clearly recruited into both the  structures 
found at 30 s and the membrane ruffles that came after (Fig. 
6,  second row,  second column;  Fig.  7, A-E).  It was then 
found in a very finely punctate pattern on the surface of the 
rounded cells at 20 min. By contrast, spectrin was not detect- 
able in the surface structures generated after 30 s, but was 
clearly present in the membrane ruffles later in the morpho- 
logical sequence (Fig. 6, third row, third column). At 20 rain, 
spectrin reveals its typical submembranous localization in 
the rounded cells. Experiments with antibodies to fimbrin 
and c~-actinin revealed that, as expected (Bretscher and We- 
ber,  1980;  Lazarides and Bun'idge,  1974),  these proteins 
were also recruited into the structures that appeared after 
30 s and into the membrane ruffles (data not shown). Myosin 
was not found in any of the cell surface structures. Before ad- 
dition of EGF it was present in a rather uniform distribution 
(Fig. 6, last row, first column) but by 30 s and at later time 
points it is clearly arranged in a striated pattern (Fig. 6, re- 
maining columns;  Fig. 7, F). 
To explore any possible correspondence between phos- 
phorylation and  association  of specific proteins  with  the 
cytoskeleton,  we  examined  the  distribution  of both  35S- 
labeled proteins and 32P-labeled phospho-proteins between 
the cytoskeleton and soluble fractions of cells before and at 
various times after treatment with EGE Since essentially the 
same results were obtained before and at each time point af- 
ter EGF addition, only the two minute time point is shown 
(Fig. 8). As described earlier (Gould et al., 1986) about half 
the  ezrin  is  cytoskeletally associated,  and  this  does  not 
change  significantly  during  EGF  stimulation;  the  phos- 
phorylated form does not show any significant preferential 
association with the soluble or cytoskeletal fractions. Essen- 
tially all  the spectrin was  recovered with the cytoskeletal 
fractions at all times after EGF addition, and no selective 
solubilization of phosphorylated spectrin could be detected. 
Discussion 
In this study, we describe the purification of human ezrin, 
a  known substrate for several protein-tyrosine kinases in- 
cluding the products of certain oncogenes (Cooper et al., 
1982), the generation of antibodies to this protein, and their 
use in following its distribution and phosphorylation in A-431 
cells before and after treatment with EGE We have also fol- 
lowed the distribution and phosphorylation of spectrin and 
myosin in these cells.  Myosin undergoes a  reorganization 
into an ordered striated pattern that is consistent with its 
probable role in the cell rounding that occurs during the sev- 
eral minutes after EGF treatment.  A  major result of this 
study is the remarkable correspondence between the rapid 
phosphorylation of ezrin and spectrin and their appearance 
in transitory surface structures that contain these proteins. 
This is in contrast to the relatively slower rate of phosphory- 
lation of p35, where phosphorylation is barely detectable 5 
min after EGF treatment and increases up to at least 4  h 
(Sawyer and Cohen,  1985). 
The purification of ezrin from chicken brush borders has 
yielded variable results (Bretscher, 1983,  1986b), whereas 
the purification of ezrin from human placenta reported here 
reliably yields milligram quantities of protein. Two proteins 
were recovered, with apparent molecular masses of 81 and 
77 kD, that cross reacted with antibodies to chicken ezrin. 
Antibodies to the human 81-kD protein reacted with chicken 
ezrin, but not the 77-kD protein. Peptide maps of  chicken ez- 
rin and human placental 81 kD are very similar, and in fact 
many of the peptides with similar mobilities have identical 
sequences (K. Gould, T. Hunter, and A. Bretscher, unpub- 
lished data); we have therefore designated this protein as hu- 
man ezrin. The 77-kD protein is always recovered as part 
of the preparation and is found in the initial extracts of pla- 
centa (Fig. 2) and in certain cultured mouse and rat lines 
(Bretscher, 1983); it is therefore unlikely to be a degradation 
product. It binds tightly to hydroxyapatite, elutes slightly be- 
hind the 81-kD  polypeptidc from Mono Q  and is clearly 
resolvable from the 81-kD polypeptide on Mono S. The an- 
tiserum to chicken ezrin cross reacts with it and the 81-kD 
polypeptide equally well (Fig. 2). Based on these findings we 
believe that the 77-kD is a distinct isoform of human ezrin, 
Figure 6. Immunofluorescence microscopy localization of actin, ezrin, spectrin, and myosin in A-431 cells at various times, indicated in 
minutes above the micrographs, after addition of EGE The plane of focus was adjusted to record the most prominent features for each 
antibody: for actin, ezrin, and spectrin at 0, 0.5-1.0, and 2-5 rain, and also for actin at 20 min; the plane of focus is on the upper surface 
near the cell periphery; for ezrin and spectrin at 20 min the focal plane is on the upper surface in the center of the cells; for myosin all 
micrographs show its distribution on the lower surface of the cells. Bar, l0 #m. 
Bretscher Ezrin and Spectrin Phosphorylation in A431 Cells  927 Figure 7. Micrographs  of cells stained with antibodies to ezrin (A-E) and the heavy chains of myosin (F). A shows the ezrin-containing 
surface structures generated 30 s after addition of EGE B-D show a group of cells 1 min after EGF addition as viewed by phase-contrast 
(B) and by immunofluorescence with ezrin antibody as seen in two focal planes (C, just above the substratum,  and D, on the upper surface 
The Journal of Cell Biology, Volume 108, 1989  928 Figure  8.  Distribution of 35S-labeled ezrin (A) and spectrin (B) 
and 32p-labeled  ezrin (A) and spectrin (B) between soluble (S) and 
cytoskeletal (C) fractions in A-431 cells 2 min after EGF addition. 
Duplicate sets of plates were labeled with 35S or 32p and soluble 
fractions and cytoskeletal fractions recovered before or at various 
times after EGF addition. Each fraction was then subjected to im- 
munoprecipitation with the respective antibodies. No changes were 
found during the time course in the distribution of 35S as a result 
of EGF treatment,  and the relative distribution of the 32p label 
paralleled the 35S label; hence only one time point is shown here. 
although protein chemical evidence, currently in progress, 
is needed to establish this relationship. 
Ezrin and/3-spectrin rapidly become phosphorylated in 
A-431  cells in response to EGE  It is likely that the EGF 
receptor directly contributes to the tyrosine phosphorylation 
of ezrin as it appears to be in a similar location in these cells 
(see below). Clearly the phosphorylation of ezrin and spec- 
trin on serine must be a result of some other protein kinase(s) 
that remain to be identified; a likely candidate is protein ki- 
nase C activated by diacylglycerol that is believed to be rap- 
idly produced in A-431 cells in response to EGF (Carpenter 
and  Cohen,  1979;  Pike and  Eakes,  1987;  Wahl  and  Car- 
penter,  1988). The reason for the apparent discrepancy be- 
tween this study where EGF was  found to stimulate ezrin 
phosphorylation on tyrosine and serine, whereas previously 
it had been reported to stimulate phosphorylation on tyrosine 
and threonine (Gould et al.,  1986), is not clear. It is worth 
noting, however, that very different conditions were used in 
the two studies  (buffer vs.  complete medium),  and A-431 
cells  with  apparently  rather  different morphologies  were 
used. We have not determined the stoichiometry of ezrin and 
spectrin phosphorylation after EGF treatment.  However, a 
previous estimate indicated that at least 10% of ezrin is phos- 
phorylated on tyrosine 2 min after EGF treatment (Gould et 
al.,  1986). The ratio of 32p to 35S, which measures relative 
phosphorylation levels,  indicated  that  spectrin  was  phos- 
phorylated to a greater extent than ezrin 2 min after EGF ad- 
dition (see Fig.  8). We therefore suspect that both proteins 
become phosphorylated to a  significant degree after EGF 
addition. 
Using antibodies to actin and ezrin we have documented 
the very rapid appearance of cell surface structures in A-431 
cells in response to EGE Within 30 s, structures that look like 
giant microvilli appear on the cell surface and contain actin, 
ezrin, ot-actinin,  and fimbrin. In a recent study, Carpentier 
et al. (1987) localized the phosphorylated form of the EGF 
receptor in A-431 cells using a phosphotyrosine antibody. 1 
min after EGF addition,  they found that the receptor was 
fully phosphorylated and localized to cell surface structures 
similar to those described here; they were not able to observe 
the induction of these structures by EGF since the receptor 
is not phosphorylated before addition of EGF and therefore 
could not be visualized.  Earlier studies indicate a  random 
distribution  for the  receptor on unstimulated  A-431  cells 
(Boonstra et al., 1985; Carpentier et al., 1986). A combina- 
tion of their (Carpentier et al., 1987) and our results indicate 
that the receptor is also recruited into these surface struc- 
tures and is therefore in a location near ezrin. The resolution 
of our experiments do not allow us to determine whether ez- 
rin phosphorylation occurs before the surface structures ap- 
pear, as would be expected if phosphorylation induces their 
formation, or is a consequence of  both the receptor and ezrin 
being recruited to these structures. It is noteworthy that the 
EGF  receptor in  A431  cells  has  been  reported to  be as- 
sociated with cytoskeletal elements (Wiegant et al.,  1986), 
so a colocalization with certain cytoskeletal proteins is not 
unexpected.  Nevertheless,  the  striking coincidence of the 
recruitment of ezrin into cell surface structures and the tran- 
sitory nature of the phosphorylation strongly suggests that 
these  two phenomena are  related.  In  the  absence of any 
knowledge of the function of ezrin,  and no clear role for 
spectrin (Mangeat and Burridge, 1984), it is difficult to pre- 
dict how these phosphorylations may alter their properties. 
It is difficult to believe that three proteins, ezrin, spectrin, 
and p35 (lipocortin), that likely play important roles in cell 
surface  structure  and  dynamics  are  gratuitously  phos- 
phorylated in response to EGF. Rather, it is tempting to spec- 
ulate that cell surface changes involving a filamentous actin 
core may respond to ezrin phosphorylation and the more bar- 
ren areas respond to phosphorylation of the spectrin and p35 
in the underlying cortical network. In the case of ezrin, the 
new method described here for its purification opens the way 
for a systematic study of  this protein with the goal of  elucidat- 
ing its function and eventually assessing the possible role of 
phosphorylation on this function. 
of the cells). Notice that structures over the entire cell surfaces and the appearance of the first membrane ruffle at the cell periphery. E 
is another group of ceils 1 min after EGF addition showing the presence of some surface structures and membrane ruffles; micrographs 
such as these suggest that membrane ruffles are not generated by coalescence of the earlier surface structures. F shows the striated appear- 
ance of myosin distribution 2 min after EGF addition. Bar, 10 #m. 
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